BIOMARKER IN OSSOTIDE INTERVENTION THERAPY OF OSTEOPOROSIS, SCREENING METHOD, AND USE

摘要

A biomarker in an ossotide intervention therapy of osteoporosis, a screening method for the biomarker, and use of the biomarker. The biomarker comprises lipids and lipoid molecules, organic acid and derivatives thereof, and/or neurotransmitter substances. The lipids and lipoid molecules are any one or several of the following substances: taurine, arachidonic acid, 1-palmitoyl-2-hydroxy-sn-glycerol-3-phosphoethanolamine, (4Z, 7Z, 10Z, 13Z, 16Z, 19Z)-4, 7, 10, 13, 16, 19-docosahexaenoic acid, 1-stearoyl-2-hydroxy-sn-glycerol-3-phosphorylcholine, taurine deoxycholic acid, taurodeoxycholic acid, and taurocholic acid.